KR100225010B1 - 초조상태 및신경기능 장해의 치료용 약학 조성물 - Google Patents

초조상태 및신경기능 장해의 치료용 약학 조성물 Download PDF

Info

Publication number
KR100225010B1
KR100225010B1 KR1019920012112A KR920012112A KR100225010B1 KR 100225010 B1 KR100225010 B1 KR 100225010B1 KR 1019920012112 A KR1019920012112 A KR 1019920012112A KR 920012112 A KR920012112 A KR 920012112A KR 100225010 B1 KR100225010 B1 KR 100225010B1
Authority
KR
South Korea
Prior art keywords
extract
pharmaceutical composition
corridalis
pharmaceutical
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019920012112A
Other languages
English (en)
Korean (ko)
Other versions
KR930001926A (ko
Inventor
베르너슈나이더
에리히에프.엘스트너
엘리자베쓰클레버
Original Assignee
마르셀 로브로엑스
스타이거 왈드 아르 쯔네이미텔베르크 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마르셀 로브로엑스, 스타이거 왈드 아르 쯔네이미텔베르크 게엠베하 filed Critical 마르셀 로브로엑스
Publication of KR930001926A publication Critical patent/KR930001926A/ko
Application granted granted Critical
Publication of KR100225010B1 publication Critical patent/KR100225010B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
    • A61K36/505—Corydalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1019920012112A 1991-07-09 1992-07-08 초조상태 및신경기능 장해의 치료용 약학 조성물 Expired - Fee Related KR100225010B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4122706.9 1991-07-09
DE4122706A DE4122706C1 (enExample) 1991-07-09 1991-07-09

Publications (2)

Publication Number Publication Date
KR930001926A KR930001926A (ko) 1993-02-22
KR100225010B1 true KR100225010B1 (ko) 1999-10-15

Family

ID=6435763

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920012112A Expired - Fee Related KR100225010B1 (ko) 1991-07-09 1992-07-08 초조상태 및신경기능 장해의 치료용 약학 조성물

Country Status (26)

Country Link
US (1) US5308619A (enExample)
EP (1) EP0535317B1 (enExample)
JP (1) JPH085796B2 (enExample)
KR (1) KR100225010B1 (enExample)
AT (1) ATE139446T1 (enExample)
AU (1) AU652262B2 (enExample)
CA (1) CA2072950A1 (enExample)
CZ (1) CZ279915B6 (enExample)
DE (2) DE4122706C1 (enExample)
DK (1) DK0535317T3 (enExample)
EE (1) EE03169B1 (enExample)
EG (1) EG20140A (enExample)
ES (1) ES2088053T3 (enExample)
GR (1) GR3020289T3 (enExample)
HU (1) HUT61668A (enExample)
IE (1) IE74691B1 (enExample)
IL (1) IL102410A (enExample)
MD (1) MD1139G2 (enExample)
MX (1) MX9204011A (enExample)
PT (1) PT100668B (enExample)
RU (1) RU2072859C1 (enExample)
SI (1) SI9200138A (enExample)
SK (1) SK279531B6 (enExample)
UA (1) UA26971C2 (enExample)
YU (1) YU48554B (enExample)
ZA (1) ZA925059B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460819A (en) * 1991-12-13 1995-10-24 Children's Medical Center Corporation Method for treating PQQ-responsive heavy metal toxicity
FR2743721B1 (fr) * 1996-01-19 1998-04-03 Innothera Lab Sa Association mineralo-phytotherapique sous forme galenique unitaire de comprimes
DK1066042T3 (da) * 1998-03-26 2006-12-18 Phytopharm Plc Steroidale saponiner til behandling af Alzheimers sygdom
US7074603B2 (en) * 1999-03-11 2006-07-11 Zeachem, Inc. Process for producing ethanol from corn dry milling
NZ514253A (en) 1999-03-11 2003-06-30 Zeachem Inc Process for producing ethanol
US6521634B2 (en) 2001-03-28 2003-02-18 The Hong Kong University Of Science & Technology Uses of dl-THP
KR20030063735A (ko) * 2002-01-23 2003-07-31 주식회사 석산터메디칼 신경성 질환 예방 및 치료를 위한 약제학적 조성물 및,실험용 동물에 신경성 질환을 일으키는 방법
US7341745B2 (en) * 2003-02-07 2008-03-11 Arizona Health Consulting, Llc Method for decreasing nicotine and other substance use in humans
MX306561B (es) * 2004-01-29 2013-01-09 Zeachem Inc Recuperacion de acidos organicos.
FR2878163B1 (fr) * 2004-11-25 2007-04-27 R & D Pharma Nouvelles compositions pharmaceutiques a visee phytotherapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR961M (enExample) * 1961-03-03 1961-11-27
DE1467868A1 (de) * 1964-10-20 1969-01-30 Dainippon Pharmaceutical Co Verfahren zur Herstellung eines gegen Geschwuere des Verdauungstraktes wirksamen Medikamentes
JPS60181023A (ja) * 1984-02-28 1985-09-14 Nitto Electric Ind Co Ltd 漢方局所麻酔性組成物

Also Published As

Publication number Publication date
PT100668B (pt) 1999-08-31
HUT61668A (en) 1993-03-01
GR3020289T3 (en) 1996-09-30
CA2072950A1 (en) 1993-01-10
EP0535317B1 (de) 1996-06-19
KR930001926A (ko) 1993-02-22
SK214392A3 (en) 1994-11-09
JPH0753392A (ja) 1995-02-28
UA26971C2 (uk) 2000-02-28
MD1139F2 (en) 1999-01-31
RU2072859C1 (ru) 1997-02-10
EG20140A (en) 1997-07-31
SI9200138A (en) 1993-03-31
ZA925059B (en) 1993-04-28
DE4122706C1 (enExample) 1993-03-04
IL102410A (en) 1998-02-22
HU9202274D0 (en) 1992-10-28
US5308619A (en) 1994-05-03
EP0535317A1 (de) 1993-04-07
ES2088053T3 (es) 1996-08-01
MD950171A (en) 1996-06-28
MX9204011A (es) 1993-07-01
MD1139G2 (ro) 1999-10-31
CZ279915B6 (cs) 1995-08-16
AU1937092A (en) 1993-01-14
YU67492A (sr) 1996-01-09
IE922226A1 (en) 1993-01-13
PT100668A (pt) 1993-09-30
JPH085796B2 (ja) 1996-01-24
DK0535317T3 (da) 1996-07-15
AU652262B2 (en) 1994-08-18
IE74691B1 (en) 1997-07-30
YU48554B (sh) 1998-11-05
IL102410A0 (en) 1993-01-14
CZ214392A3 (en) 1993-02-17
ATE139446T1 (de) 1996-07-15
EE03169B1 (et) 1999-04-15
SK279531B6 (sk) 1998-12-02
DE59206608D1 (de) 1996-07-25

Similar Documents

Publication Publication Date Title
Orhan et al. In-vivo assessment of antidiabetic and antioxidant activities of grapevine leaves (Vitis vinifera) in diabetic rats
US11331363B2 (en) Phytocomplexes exhibiting multiple, synergistic antioxidant activities useful in foods, dietary supplements, cosmetics and pharmaceutical preparations
KR100225010B1 (ko) 초조상태 및신경기능 장해의 치료용 약학 조성물
Savych et al. Antioxidant activity in vitro of antidiabetic herbal mixtures
Hussain et al. Comparative in vitro analysis of anti-diabetic activity of Indo-Pak black cardamom (Amomum subulatum Roxb.) and Chinese black cardamom (Amomum tsao-ko Crevost et Lemaire)
Campuzano-Bublitz et al. Acute and chronic anti-hyperglycemic effect of Prosopis ruscifolia extract in normoglycemic and alloxan-induced hyperglycemic rats
KR0168748B1 (ko) 혈당 강하용 인삼 음료와 소프트 캡슐
Maidadi et al. Efficacy of Rytigynia senegalensis Blume on Free Radical Scavenging, Inhibition of α‐Amylase and α‐Glucosidase Activity, and Blood Glucose Level
Nkanu et al. In vivo. hypolipidemic and hypoglycemic effects of aqueous extract of Spondias mombin leaves and detoxification of reactive oxygen species in alloxan-induced diabetic rats
KR100473531B1 (ko) 변방 소풍순기원 생약 복합제 추출물을 함유하는 당뇨병예방 및 치료를 위한 조성물
Chidi et al. Anti-hyperglycemic and anti-oxidant activities of methanol extract of Gongronema latifolium
LT3355B (en) Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunctions
KR20060034879A (ko) 항당뇨 효과를 나타내는 발효구아바 조성물
TW202442255A (zh) 磷酸二酯酶5抑制劑
Pingale et al. Syzygium cumini Protects Diabetic Wistar Rats Against Rosiglitazone-Induced Cardiotoxicity and Hepatotoxicity
Ikechukwu et al. Polyherbal formular 5 normalises blood glucose level and reverses complications in diabetes via the upregulation of AMPKinase, GLUT 1 and GLUT 4 activities in albino rats
KR100775964B1 (ko) 항산화 효과가 있는 삼백초 사탕 제조 방법
CN120585963A (zh) 一种治疗阿尔兹海默症的药物组合及其制备和检测方法
CN120392802A (zh) 用于抑制α-葡糖苷酶、脂肪酶和黄嘌呤氧化酶的组合物和方法
BRAIN Journal of Global Trends in Pharmaceutical Sciences
OSO et al. Croatian Journal of Food Science and Technology
MXPA97003308A (en) Medical composition for diabe
HK1025246A1 (en) The extract of pine needle and the use thereof
HK1025246B (en) The extract of pine needle and the use thereof
FR3031456A1 (fr) Extraits de sapin abies alba, compositions et utilisations

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20020716

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20020716